top
Search terms
Results 1 - 10 of 16 - ordered by :
Pages: 1 2
Escardio

Professor Deepak L. Bhatt (Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA) describes the rationale for the study, which is the largest trial in type 2 ...

Date : 02/09/2019
Escardio

The combination of ticagrelor and aspirin reduces ischaemic events compared with aspirin alone in patients with stable coronary artery disease and diabetes. Senior author Professor Deepak L. Bhatt ...

Date : 01/09/2019
Escardio

Senior author Professor Philippe Gabriel Steg of Hospital Bichat, Paris, France said: “Treatment with ticagrelor and aspirin also increased major bleeding relative to aspirin alone, but there ...

Date : 01/09/2019
Escardio

The investigator-initiated, randomised, open-label GLOBAL LEADERS trial included almost 16,000 patients scheduled to undergo percutaneous coronary intervention for stable coronary artery disease ...

Date : 28/08/2018
Escardio

Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from ...

Date : 27/08/2018
Escardio

The long-term follow-up of patients in the NIPPON (NoborI dual antiplatelet therapy as aPPrOpriate DuratioN) study is presented today at ESC Congress 2017. “These findings support and ...

Date : 28/08/2017
Escardio

Results of the NIPPON (NoborI dual antiplatelet therapy as aPPrOpriate DuratioN) study, presented at ESC Congress 2016, showed similar rates of “net adverse clinical and cerebrovascular ...

Date : 28/08/2016
Escardio

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 21/10/2015
Escardio

While the investigator-initiated study showed that DAPT (a combination of aspirin and the P2Y12-receptor blocker clopidogrel) does not decrease the rate of major adverse cardiovascular and ...

Date : 31/08/2015
Escardio

EMBARGO : 31 August 2015 at 14:30 BST “Coronary artery disease and acute coronary syndromes are the cause of death and disability in many patients,” said Dr Raban Jeger, interventional ...

Date : 31/08/2015